UBS ASSET MANAGEMENT AMERICAS LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 150 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$133,005,000
-40.3%
107,262
+48.4%
0.00%
Q1 2017$222,620,000
+129330.2%
72,279
+71.7%
0.00%
Q4 2016$172,000
-63.9%
42,097
-43.9%
0.00%
-100.0%
Q3 2016$477,000
-73.9%
75,097
-77.9%
0.00%
-50.0%
Q2 2016$1,828,000
-83.3%
339,097
-74.1%
0.00%
-84.6%
Q1 2016$10,954,000
+9.6%
1,308,762
+3.5%
0.01%
+18.2%
Q4 2015$9,992,000
-10.2%
1,264,799
-3.2%
0.01%
-8.3%
Q3 2015$11,122,000
+2.4%
1,306,844
+48.8%
0.01%
+20.0%
Q2 2015$10,859,000
+5.0%
878,144
+0.9%
0.01%0.0%
Q1 2015$10,338,000
+6.7%
870,244
+1.5%
0.01%
+11.1%
Q4 2014$9,686,000
+31.4%
857,197
+2.1%
0.01%
+28.6%
Q3 2014$7,370,000
+25.6%
839,397
+4.3%
0.01%
+16.7%
Q2 2014$5,868,000
+44.6%
804,9970.0%0.01%
+50.0%
Q1 2014$4,057,000
-3.9%
804,997
+1.8%
0.00%
-20.0%
Q4 2013$4,221,000
+41.6%
790,497
+0.8%
0.01%
+25.0%
Q3 2013$2,981,000
+1131.8%
784,597
+2085.7%
0.00%
Q2 2013$242,00035,8970.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 775,571$2,389,0000.93%
KEMPNER CAPITAL MANAGEMENT INC. 148,985$459,0000.31%
Yakira Capital Management, Inc. 248,420$765,0000.27%
GARRISON BRADFORD & ASSOCIATES INC 87,700$270,0000.24%
Cannell & Co. 1,212,478$3,734,0000.13%
LeJeune Puetz Investment Counsel LLC 3,976$180,0000.13%
ALPINE WOODS CAPITAL INVESTORS, LLC 726,000$2,236,0000.12%
Virtus ETF Advisers LLC 198,735$612,0000.11%
STONERIDGE INVESTMENT PARTNERS LLC 199,227$614,0000.08%
Birchview Capital, LP 44,000$136,0000.08%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders